Maravai Lifesciences Holdings (MRVI) Interest Expenses (2020 - 2025)
Maravai Lifesciences Holdings has reported Interest Expenses over the past 6 years, most recently at $6.6 million for Q4 2025.
- Quarterly results put Interest Expenses at $6.6 million for Q4 2025, down 41.8% from a year ago — trailing twelve months through Dec 2025 was $27.0 million (down 43.41% YoY), and the annual figure for FY2025 was $27.0 million, down 43.41%.
- Interest Expenses for Q4 2025 was $6.6 million at Maravai Lifesciences Holdings, down from $6.8 million in the prior quarter.
- Over the last five years, Interest Expenses for MRVI hit a ceiling of $15.4 million in Q4 2023 and a floor of $2.7 million in Q1 2022.
- Median Interest Expenses over the past 5 years was $7.7 million (2021), compared with a mean of $8.6 million.
- Biggest five-year swings in Interest Expenses: tumbled 66.3% in 2022 and later skyrocketed 344.18% in 2023.
- Maravai Lifesciences Holdings' Interest Expenses stood at $7.0 million in 2021, then skyrocketed by 44.97% to $10.2 million in 2022, then surged by 51.28% to $15.4 million in 2023, then dropped by 26.86% to $11.3 million in 2024, then crashed by 41.8% to $6.6 million in 2025.
- The last three reported values for Interest Expenses were $6.6 million (Q4 2025), $6.8 million (Q3 2025), and $6.8 million (Q2 2025) per Business Quant data.